Search
Sporotrichum pruinosum
go.drugbank.com/drugs/DB10846ApprovedSporotrichum pruinosum is a fungus which can provoke allergic reactions. Sporotrichum pruinosum extract is used in allergenic testing.
Mixtures: C Mold Mixture, C Mold MixtureStachybotrys chartarum
go.drugbank.com/drugs/DB10847ApprovedStachybotrys chartarum is a fungus which can provoke allergic reactions. Stachybotrys chartarum extract is used in allergenic testing.
Mixtures: C Mold Mixture, C Mold MixtureSyncephalastrum racemosum
go.drugbank.com/drugs/DB10848ApprovedSyncephalastrum racemosum is a fungus which can provoke allergic reactions. Syncephalastrum racemosum extract is used in allergenic testing.
Mixtures: C Mold Mixture, C Mold MixtureEpidermophyton floccosum
go.drugbank.com/drugs/DB10870ApprovedEpidermophyton floccosum is a fungus which can provoke allergic reactions. Epidermophyton floccosum extract is used in allergenic testing.
Pleospora betae
go.drugbank.com/drugs/DB10936ApprovedPleospora betae is a fungus which can provoke allergic reactions. Pleospora betae extract is used in allergenic testing.
Trichophyton tonsurans
go.drugbank.com/drugs/DB10970ApprovedTrichophyton tonsurans is a fungus which can provoke allergic reactions. Trichophyton tonsurans extract is used in allergenic testing.
Trichophyton verrucosum
go.drugbank.com/drugs/DB11295ApprovedTrichophyton verrucosum is a fungus which can provoke allergic reactions. Trichophyton verrucosum extract is used in allergenic testing.
Bumadizone
go.drugbank.com/drugs/DB13286ApprovedBumadizone has been approved for use in Germany and Austria, it is a drug with anti-inflammatory, antipyretic, and analgesic properties, and was marketed for the treatment of both rheumatoid arthritis … Its use is restricted to these conditions, due to risks this drug poses [L5650].
Categories: Non COX-2 selective NSAIDSAclarubicin
go.drugbank.com/drugs/DB11617InvestigationalSynonyms: Aclacinomycin ACategories: Topoisomerase II InhibitorsUpanovimab
go.drugbank.com/drugs/DB16505InvestigationalUpanovimab (SCTA01) was under investigation in clinical trials (NCT04683328, NCT04644185, NCT04709328 and NCT05156645) to evaluate its safety and efficacy in patients with severe COVID-19
Synonyms: IMMUNOGLOBULIN G1, ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN) (HUMAN-MUS MUSCULUS MONOCLONAL SCTA01 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL SCTA01 .